The effects of vitamin K supplementation and vitamin K antagonists on progression of vascular calcification: ongoing randomized controlled trials
Conclusion
Vitamin K deficiency may be a modifiable cardiovascular risk factor in the haemodialysis population. Conversely, vitamin K antagonists may aggravate VC burden in haemodialysis patients. Several ongoing trials may provide an answer to these questions in the near future.
Source: CKJ: Clinical Kidney Journal - Category: Urology & Nephrology Authors: Caluwe, R., Pyfferoen, L., De Boeck, K., De Vriese, A. S. Tags: CKD-MBD Source Type: research
More News: Atrial Fibrillation | Bleeding | Cardiology | Cardiovascular | Clinical Trials | Coumadin | CT Scan | Databases & Libraries | Dialysis | Heart | Hemodialysis | Stroke | Study | Urology & Nephrology | Vitamin K | Vitamin K Deficiency | Vitamins | Warfarin